{"id":2523,"date":"2014-06-10T11:58:18","date_gmt":"2014-06-10T01:58:18","guid":{"rendered":"https:\/\/orthocell.com\/us\/?p=2523"},"modified":"2021-09-16T15:03:24","modified_gmt":"2021-09-16T05:03:24","slug":"biotech-orthocell-looks-to-raise-8m-in-ipo","status":"publish","type":"post","link":"\/americas\/biotech-orthocell-looks-to-raise-8m-in-ipo\/","title":{"rendered":"Biotech Orthocell looks to raise $8m in IPO"},"content":{"rendered":"<p>Details of Orthocell&#8217;s upcoming ASX launch have been featured in the Australian Financial Review (AFR).<\/p>\n<p>An excerpt from the article:<\/p>\n<p>&#8220;Orthocell , a local biotechnology company that sells customised injectable human stem cell therapy for tendon injuries, is set to debut on the ASX in July as an $33 million company.<\/p>\n<p>Up to 20 million shares are on offer in the float, priced at $0.40 per share to raise a maximum of $8 million. If the full amount is raised there will be a total of 77.5 million shares in the company at listing, giving it a market capitalisation of $82.5 million.&#8221;<\/p>\n<p>Read the article <a href=\"https:\/\/www.afr.com\/companies\/healthcare-and-fitness\/biotech-orthocell-looks-to-raise-8m-in-ipo-20140610-iwo16\" target=\"_blank\" rel=\"noopener\">HERE.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Details of Orthocell&#8217;s upcoming launch on the ASX has been featured in the Australian Financial Review (AFR).<\/p>\n","protected":false},"author":2,"featured_media":2621,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-2523","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-media"],"aioseo_notices":[],"_links":{"self":[{"href":"\/americas\/wp-json\/wp\/v2\/posts\/2523","targetHints":{"allow":["GET"]}}],"collection":[{"href":"\/americas\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"\/americas\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/comments?post=2523"}],"version-history":[{"count":2,"href":"\/americas\/wp-json\/wp\/v2\/posts\/2523\/revisions"}],"predecessor-version":[{"id":2535,"href":"\/americas\/wp-json\/wp\/v2\/posts\/2523\/revisions\/2535"}],"wp:featuredmedia":[{"embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/media\/2621"}],"wp:attachment":[{"href":"\/americas\/wp-json\/wp\/v2\/media?parent=2523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/categories?post=2523"},{"taxonomy":"post_tag","embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/tags?post=2523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}